Americans may be overpaying for prescription drugs in ways they never see. Hidden pricing practices inside the Pharmacy Benefit Manager system (PBM) system can quietly increase what patients pay at the pharmacy counter, push up employer-sponsored premiums and expose taxpayers to billions in added costs.

To talk about this, we’re joined by Anthony Ciaccia, CEO and co-founder of 46brooklyn Research, a nonprofit organization dedicated to improving the transparency and accessibility of drug pricing data for the American public and also publishes original research to shine light on the hidden and complex underbelly of the drug supply chain.

<p>Americans may be overpaying for prescription drugs in ways they never see. Hidden pricing practices inside the Pharmacy Benefit Manager system (PBM) system can quietly increase what patients pay at the pharmacy counter, push up employer-sponsored premiums and expose taxpayers to billions in added costs.</p>
<p>To talk about this, we&rsquo;re joined by Anthony Ciaccia, CEO and co-founder of 46brooklyn Research, a nonprofit organization dedicated to improving the transparency and accessibility of drug pricing data for the American public and also publishes original research to shine light on the hidden and complex underbelly of the drug supply chain.</p>